Gilead Sciences Inc. - GILD (NASDAQ-GS)

76.31
0.00 (0.00%)
Quotes delayed 15 mins. Currently October 17, 2018 6:19:58 AM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Gilead develops and markets products in the HIV/AIDS, liver diseases, respiratory and cardiovascular therapeutic areas

Key Financials

Day Range:73.04 - 76.44
52 Week Range:64.27 - 89.54
Open:73.30
Shares:1.30B
Market Cap:98.92B
EPS:1.69
P/E Ratio:43.10
Div Yield:2.99
Performance
Previous close
No Chart Available
Purchase GILD in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of GILD not only as a single stock, but also as part of a motif.
Professional Motifs with GILD
Biotech Breakthroughs
Biotech Breakthroughs 5.6% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
Cash Flow Kings
Cash Flow Kings 8.9% 1 YR RTN Steady cash flow. Low stock price. What’s not to like? These guys are flying below the radar, and may be worth a look.
Dividend Stars
Dividend Stars 4.2% 1 YR RTN These dividend payers provide consistency and growth all while offering an attractive composite yield.
View all professional motifs with GILD
Community Motifs with GILD
Innovation Ahead
Innovation Ahead 2.0% 1 YR RTN
nrynnv April 2017 DM buys
nrynnv April 2017 DM buys 15.2% 1 YR RTN
Medical Marijuana
Medical Marijuana 3.3% 1 YR RTN
WATCH LIST
WATCH LIST 16.8% 1 YR RTN
View all community motifs with GILD
What Others Think About GILD
Charlie Bilello
% Below 52-week high...
$AMGN : -4%
$BRKB : -5%
$JPM : -7%
$AAPL : -7%
$CSCO : -8%
$MSFT : -9%
$V : -11%
$BAC : -12%
$ADBE : -14%
$AMZN : -14%
$GOOGL : -15%
$NVDA : -16%
$GILD : -16%
$PYPL : -20%
$INTC : -22%
$NFLX : -23%
$FB : -31%
$BIDU : -32%
$BABA : -34%
$TCEHY : -42%
$NTES : -44%
$TWTR : -44%
447 847
Caesar
$RHHBY #hbv programs in clinical development : probably one of the most ambitious with $JNJ ( $GILD far behind...)
---> TLR7 (stimulate innate immune response) : three candidates
---> LNA (inhibit RNA transcript) : one candidate
---> CpAM (capsid inhibitor) : two candidates
BH1377
@GeryDIVRY Hi Gery. You've posted this multiple times, but it's not clear from your posts if you're +/- on CBAY (apologize if I missed it). The article is pro $GILD (as am I), but a lot of people won't read or understand the article. Can you state your position on $CBAY , $ICPT & $GILD ?
Transcript Daily
Contrasting Gilead Sciences $GILD & Fennec Pharmaceuticals $FENC zpr.io/6SnHT
Watchlist News
Head to Head Analysis: Gilead Sciences $GILD and NOVOZYMES A/S/S $NVZMY zpr.io/6Sntt
Behavioral Finance
RT @gcbioinv : Informative article about allogeneic vs autologous CAR-T therapies: loncarfunds.com/CNCR_ETF_Resea…

Nice work @bradloncar and @BillK…
6
Behavioral Finance
When do you expect first new meaninful clinical results in Allogeneic Car T cell technology?
$CLLS $ALLO $ATRA $ZIOP $PFE $CELG $GILD $ALCLS $ALLO
1
Related Companies Within The Biotechnology Sector
Amgen Inc. - 202.34
AMGN
Biogen Inc. - 338.61
BIIB
CELG
SHPG
Shire plc - 175.51
SHPG
Illumina Inc. - 326.58
ILMN